SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 116 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $134,084 | +52.8% | 15,756 | +83.5% | 0.00% | – |
| Q1 2024 | $87,769 | +113.6% | 8,588 | +14.5% | 0.00% | – |
| Q4 2023 | $41,089 | +83.1% | 7,498 | +26.3% | 0.00% | – |
| Q3 2023 | $22,438 | -64.8% | 5,936 | -37.6% | 0.00% | – |
| Q2 2023 | $63,717 | +3912.4% | 9,510 | +3797.5% | 0.00% | – |
| Q1 2023 | $1,588 | -21.1% | 244 | +3.4% | 0.00% | – |
| Q4 2022 | $2,013 | +101.3% | 236 | +55.3% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 152 | +2.7% | 0.00% | – |
| Q2 2022 | $1,000 | -92.9% | 148 | -96.5% | 0.00% | – |
| Q1 2022 | $14,000 | -75.4% | 4,193 | -50.9% | 0.00% | – |
| Q4 2021 | $57,000 | -66.3% | 8,532 | -49.5% | 0.00% | – |
| Q3 2021 | $169,000 | +838.9% | 16,911 | +2776.0% | 0.00% | – |
| Q2 2021 | $18,000 | -90.6% | 588 | -86.6% | 0.00% | – |
| Q1 2021 | $191,000 | – | 4,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $34,149,805 | 10.69% |
| K2 PRINCIPAL FUND, L.P. | 2,461,672 | $20,948,829 | 3.90% |
| Nextech Invest Ltd. | 1,910,029 | $16,254,347 | 2.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $94,273,159 | 1.57% |
| Orbimed Advisors | 9,240,887 | $78,639,948 | 1.55% |
| RA Capital Management | 10,860,977 | $92,426,914 | 1.22% |
| SECTORAL ASSET MANAGEMENT INC | 236,937 | $2,016,334 | 0.82% |
| Sio Capital Management, LLC | 217,864 | $1,854,023 | 0.50% |
| DAFNA Capital Management LLC | 239,194 | $2,035,541 | 0.49% |
| ClariVest Asset Management LLC | 287,596 | $2,447,442 | 0.25% |